PT Siloam International Hospitals (SILO) Q4 2025 earnings summary

Executive summary

• Consolidated financial statements for the years ended December 31, 2025 and 2024 were audited and received an unqualified opinion, confirming fair presentation in accordance with Indonesian Financial Accounting Standards.

• The company operates a network of hospitals and healthcare facilities across Indonesia, with significant expansion and capital investments in property and equipment.

• Management and Employee Stock Option Plans (MESOP) were executed, with shares allocated and distributed to employees and management.

Financial highlights

• Revenue for 2025 reached Rp12,847,434 million, up from Rp12,207,563 million in 2024 (year-over-year growth).

• Net income attributable to owners was Rp1,112,663 million in 2025, up from Rp902,152 million in 2024.

• Earnings per share (EPS) increased to Rp85.68 in 2025 from Rp69.49 in 2024.

• Total assets as of December 31, 2025 were Rp14,498,064 million, up from Rp14,206,336 million at year-end 2024.

• Total equity increased to Rp9,928,969 million in 2025 from Rp8,751,628 million in 2024.

Outlook and guidance

• The company continues to invest in hospital expansion and modernization, with construction in progress and new facilities expected to be completed between 2026 and 2028.

• Management is evaluating the potential acquisition of First REIT's hospital asset portfolio in Indonesia, subject to negotiation and finalization of definitive agreements.